person · Reporting owner
Mendelson Daniel Newman
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC.CSBR · Entity 7013 | Director | November 05, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHAMPIONS ONCOLOGY, INC.
Report date November 05, 2025 · Filed November 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.80 · Expires 2035-11-05 | Direct | 13,790 |
Reported balance
After 2025-11-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-05 · Grant · Acquired 13,790 · Balance 13,790 F1: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2025 Filed Nov 7, 2025 16:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 13,790 | $6.80 Strike: $6.80 | $93,772.00 |
DisclosureSEC source: 0001628280-25-050491 · wk-form4_1762532316.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2035-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively. Read SEC document |
| November 12, 2024 Filed Nov 18, 2024 16:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 21,590 | $4.64 Strike: $4.64 | $100,177.60 |
DisclosureSEC source: 0001628280-24-048205 · wk-form4_1731946727.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,590 Underlying: Common Stock · 21,590 shares Expires 2034-11-12 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 16:45 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $6.50 | $6,500.00 |
DisclosureSEC source: 0001628280-24-001334 · wk-form4_1705423535.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,625 Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 17:47 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,000 | $6.27 | $12,540.00 |
DisclosureSEC source: 0001628280-24-001231 · wk-form4_1705081618.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,625 Read SEC document |
| January 10, 2024 Filed Jan 11, 2024 15:57 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,944 | $6.31 | $18,576.64 |
DisclosureSEC source: 0001628280-24-001118 · wk-form4_1704988646.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,625 Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 13:57 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 3,000 | $6.25 | $18,750.00 |
DisclosureSEC source: 0001628280-24-001002 · wk-form4_1704895046.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,681 Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 14:08 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,000 | $6.15 | $6,150.00 |
DisclosureSEC source: 0001628280-24-000896 · wk-form4_1704809286.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,681 Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 20:11 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,000 | $6.09 | $12,180.00 |
DisclosureSEC source: 0001628280-24-000825 · wk-form4_1704744709.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,681 Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 19:54 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 3,000 | $6.12 | $18,360.00 |
DisclosureSEC source: 0001628280-24-000820 · wk-form4_1704743687.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,681 Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 18:37 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 500 | $5.83 | $2,915.00 |
DisclosureSEC source: 0001628280-24-000388 · wk-form4_1704393413.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,681 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 16:48 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,500 | $4.92 | $12,300.00 |
DisclosureSEC source: 0001628280-23-042662 · wk-form4_1703609285.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,181 Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 19:31 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,100 | $4.82 | $10,122.00 |
DisclosureSEC source: 0001628280-23-042467 · wk-form4_1703187064.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,681 Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 14:48 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $4.75 | $23,750.00 |
DisclosureSEC source: 0001628280-23-042096 · wk-form4_1703083724.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,581 Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 16:58 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 26,220 | $5.51 Strike: $5.51 | $144,472.20 |
DisclosureSEC source: 0001628280-23-037249 · wk-form4_1699376309.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,220 Underlying: Common Stock · 26,220 shares Expires 2033-11-03 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively. Read SEC document |
| October 11, 2023 Filed Oct 13, 2023 16:48 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $6.40 | $32,000.00 |
DisclosureSEC source: 0001628280-23-034348 · wk-form4_1697215682.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,081 Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 13:45 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,100 | $6.41 | $7,051.00 |
DisclosureSEC source: 0001628280-23-034231 · wk-form4_1697031899.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,081 Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 14:02 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,530 | $6.48 | $9,914.40 |
DisclosureSEC source: 0001628280-23-034119 · wk-form4_1696946525.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,981 Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 11:10 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,000 | $6.47 | $12,940.00 |
DisclosureSEC source: 0001628280-23-034004 · wf-form4_169659064199177.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,451 Read SEC document |
| October 04, 2023 Filed Oct 4, 2023 21:30 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $6.40 | $32,000.00 |
DisclosureSEC source: 0001628280-23-033842 · wf-form4_169645502108268.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,451 Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 21:31 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 2,500 | $6.30 | $15,750.00 |
DisclosureSEC source: 0001628280-23-033843 · wf-form4_169645505352839.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,451 Read SEC document |
| September 29, 2023 Filed Oct 16, 2023 13:53 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 4,000 | $6.16 | $24,640.00 |
DisclosureSEC source: 0001628280-23-034409 · wk-form4_1697464428.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,581 Read SEC document |
| September 28, 2023 Filed Oct 16, 2023 13:52 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $6.22 | $31,100.00 |
DisclosureSEC source: 0001628280-23-034407 · wk-form4_1697464350.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,581 Read SEC document |
| September 27, 2023 Filed Oct 16, 2023 13:51 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 1,500 | $5.95 | $8,925.00 |
DisclosureSEC source: 0001628280-23-034405 · wk-form4_1697464252.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,581 Read SEC document |
| September 26, 2023 Filed Sep 27, 2023 13:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $5.65 | $28,250.00 |
DisclosureSEC source: 0001628280-23-033077 · wf-form4_169582300558310.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,951 Read SEC document |
| September 22, 2023 Filed Sep 25, 2023 18:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 3,812 | $5.50 | $20,966.00 |
DisclosureSEC source: 0001628280-23-032917 · wf-form4_169566833604307.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,951 Read SEC document |
| September 21, 2023 Filed Sep 25, 2023 18:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $5.51 | $27,550.00 |
DisclosureSEC source: 0001628280-23-032918 · wf-form4_169566835107905.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,139 Read SEC document |
| September 20, 2023 Filed Sep 25, 2023 18:59 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 4,018 | $5.51 | $22,139.18 |
DisclosureSEC source: 0001628280-23-032919 · wf-form4_169566837025005.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,139 Read SEC document |
| September 19, 2023 Filed Sep 25, 2023 19:00 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 5,000 | $5.28 | $26,400.00 |
DisclosureSEC source: 0001628280-23-032920 · wf-form4_169566838737069.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,121 Read SEC document |
| November 01, 2022 Filed Aug 17, 2023 16:07 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 19,430 | $7.00 Strike: $7.00 | $136,010.00 |
DisclosureSEC source: 0001628280-23-029777 · wf-form4_169228846413492.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,430 Underlying: Common Stock · 19,430 shares Expires 2032-11-01 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:31 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 13,614 | $10.10 Strike: $10.10 | $137,501.40 |
DisclosureSEC source: 0001628280-21-022606 · wf-form4_163649710448444.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,614 Underlying: Common Stock · 13,614 shares Expires 2031-11-05 F1 · derivative.exercise_date: The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 22:01 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 10,000 | $11.96 Strike: $11.96 | $119,600.00 |
DisclosureSEC source: 0001628280-20-017368 · wf-form4_160763770404258.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-12-08 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on December 8, 2020, March 8, 2021, June 8, 2021 and September 8, 2021, respectively. Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 300 | $5.89 | $1,767.00 |
DisclosureSEC source: 0001628280-20-004374 · wf-form4_158560175582059.xml · nonDerivative · entry 5 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,746 Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 700 | $5.90 | $4,130.00 |
DisclosureSEC source: 0001628280-20-004374 · wf-form4_158560175582059.xml · nonDerivative · entry 4 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,446 Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 100 | $5.97 | $597.00 |
DisclosureSEC source: 0001628280-20-004374 · wf-form4_158560175582059.xml · nonDerivative · entry 3 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,746 Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 100 | $5.99 | $599.00 |
DisclosureSEC source: 0001628280-20-004374 · wf-form4_158560175582059.xml · nonDerivative · entry 2 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,646 Read SEC document |
| March 26, 2020 Filed Mar 30, 2020 20:56 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 20 | $6.00 | $120.00 |
DisclosureSEC source: 0001628280-20-004374 · wf-form4_158560175582059.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,546 Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 19:00 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | PurchaseCommon Stock | 26 | $5.50 | $143.00 |
DisclosureSEC source: 0001628280-20-004087 · wf-form4_158524923075589.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,526 Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 10,000 | $3.21 Strike: $3.21 | $32,100.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · derivative · entry 6 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F4 · derivative.exercise_date: The options vest and are exercisable over a nine month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8 2018, respectively. Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 10,000 | $1.59 Strike: $1.59 | $15,900.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · derivative · entry 5 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F3 · derivative.exercise_date: The options vest and are exercisable over a nine month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively. Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionOption to purchase Common Stock · Derivative | 10,000 | $5.46 Strike: $5.46 | $54,600.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · derivative · entry 4 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options vest and are exercisable over a nine month period, with vesting to occur on November 2, 2015, February 2, 2016, May 2, 2016 and August 2, 2016, respectively. Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 10,000 | $3.21 | $32,100.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · nonDerivative · entry 3 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 10,000 | $1.59 | $15,900.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · nonDerivative · entry 2 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Nov 3, 2020 22:44 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 10,000 | $5.46 | $54,600.00 |
DisclosureSEC source: 0001628280-20-015400 · wf-form4_160444348372369.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Nov 3, 2020 22:39 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionWarrant to purchase shares of Common Stock · Derivative | 34,375 | $5.76 Strike: $5.76 | $198,000.00 |
DisclosureSEC source: 0001628280-20-015396 · wf-form4_160444316482521.xml · derivative · entry 2 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,375 shares Expires 2020-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F1 · shares: Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the "Reverse Stock Split"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split. F2 · derivative.exercise_date: The options were immediately exercisable upon grant on March 13, 2015. Read SEC document |
| February 11, 2020 Filed Nov 3, 2020 22:39 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | Exercise / conversionCommon Stock | 34,375 | $5.76 | $198,000.00 |
DisclosureSEC source: 0001628280-20-015396 · wf-form4_160444316482521.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 22:18 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 10,000 | $5.43 Strike: $5.43 | $54,300.00 |
DisclosureSEC source: 0001628280-19-013533 · wf-form4_157307868493803.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-11-03 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 22:02 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | SaleCommon Stock | 5,000 | $13.75 | $68,750.00 |
DisclosureSEC source: 0001628280-18-014013 · wf-form4_154171453610938.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 16:39 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantOption to purchase Common Stock · Derivative | 10,000 | $12.73 Strike: $12.73 | $127,300.00 |
DisclosureSEC source: 0001628280-18-013556 · wf-form4_154143595175126.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2023-11-01 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018, February 1, 2019, May 1, 2019 and August 1, 2019, respectively. Read SEC document |
| September 20, 2018 Filed Oct 5, 2018 14:30 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | SaleCommon Stock | 8,333 | $13.02 | $108,495.66 |
DisclosureSEC source: 0001628280-18-012338 · wf-form4_153874984226796.xml · nonDerivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 18:31 UTC | CHAMPIONS ONCOLOGY, INC. CSBR · Entity 7013 | GrantStock Options · Derivative | 10,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001144204-16-131340 · v452158_4.xml · derivative · entry 1 Mendelson Daniel Newman · CIK 0001327897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2021-10-31 F1 · derivative.exercise_date: The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.